Starbucks Archives - CDR – Chain Drug Review

Donald joins Albertsons as president, COO

March 19, 2018 by Scot Meyer and Chain Drug Review Albertsons Cos., Bob Miller, Haggen, Jim Donald, Starbucks, Susan Morris, Wayne Denningham 2018, Issue 03-19-2018, Issues, News

BOISE, Idaho — Albertsons Cos. has tapped retail veteran Jim Donald, former president and chief executive officer of Starbucks Corp., to serve as its new president and chief operating officer. In his new role, Donald will have responsibility for the operations of the retailer’s more than 2,300 stores and will help drive the growth of

Is it doomsday for retail chains? Not yet

August 6, 2016 by Wendy Liebmann and Chain Drug Review 2016 How America Shops MegaTrends, Kith, Kroger, Lorna Jane, Organic Pharmacy, Starbucks, Wellpath, Wendy Liebmann, Whole Foods Markets, WSL Strategic Retail 2016, Issue 08-08-2016, Issues, Opinion

The continuous roller coaster of retail sales results could make even the greatest optimist weep. In recent months, when retailers like Macy’s, Nordstrom, Kohl’s, J.C. Penney and Target reported less than stellar results, it was hard not to take on a Chicken Little view that the sky was falling. Retailers blamed a variety of factors: